Galvany Pharma Limited
- Active
- Small
- 4 years
- 3 employees
- £2,395,434 (cur assets)
- 1m-15m
- Regular importer
- Virtual address
- 4 directors
- No owners
- Stevenage
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
Field of Operation
Website
Social media
Summary
Galvany Pharma Limited is a small, active pharmaceutical company based in Stevenage, UK, founded three years ago in March 2022. With £1,987,243 in assets, it operates from a virtual address – thirty-one companies share the same location – and is managed by four directors, though no owners are officially listed. The company regularly imports pharmaceutical products, with recent activity recorded in December 2024.
The company’s website highlights Galvany Pharma as a UK-based firm specializing in the development and commercialization of niche pharmaceuticals. It boasts a portfolio of high-quality products targeting unmet clinical needs and aims to provide affordable medicines. Galvany leverages strategic partnerships with European and global manufacturers and has a direct presence in the UK alongside several commercial partnerships, enabling a global reach. The company’s leadership team emphasizes integrity, customer focus, and operational excellence. Recent news includes participation in the Current Issues in Palliative Care event and the launch of Levorol 6.25mg tablets.
Financially, Galvany Pharma’s situation presents a mixed picture. Cash reserves decreased by 31%, falling to £680,000, while creditors dramatically increased by 2000%, reaching £110,000. Current assets remained relatively stable at £2,000,000, but equity experienced a significant drop of 480%, resulting in a negative balance of -£120,000. Trade debtors have also increased considerably, by 410%. The company meets the criteria for a small business, with turnover under £10.2 million, assets under £5.1 million, and fewer than 50 employees. The lack of an auditor is consistent with its status as a small company.
Overall, Galvany Pharma appears to be facing some financial challenges, with a significant drop in equity and increased liabilities. While its focus on niche pharmaceuticals and strategic partnerships suggests potential for growth, the company will need to manage its finances carefully to ensure its long-term sustainability.
Registered in England/Wales under the registration number 13977261, with a registered address at SG1 2DX, England, Stevenage, Business & Technology Centre, Bessemer Drive.
WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Managers
-
Individual
- 4 years
- 2
-
Resident of United Kingdom
-
Individual
- 4 years
- 1
-
Resident of United Kingdom
-
Individual
- 4 years
- 7
-
Resident of United Kingdom
-
Individual
- 4 years
- 2
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted two months ago.
Last news
-
Confirmation statement made on 2026-03-06 with updatesDownload 4 pages pdf report
-
Total exemption full accounts made up to 2024-12-31Download 8 pages pdf report
-
Confirmation statement made on 2025-03-06 with updatesDownload 5 pages pdf report
Importer profile by HS codes
Click on the map to see detailed UK statistics on HS code, including companies list.
Import HS codes in detail
Last imported products
Click on items to see detailed UK statistics on HS code, including companies list.
* Warning: Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Similar importers
FAQ about Galvany Pharma Limited
Looking for leads in the UK?
Book a demo—see how CorpSignals can help you find UK leads.